Drugs / stannic protoporfin
stannic protoporfin
also known as
NSC-267099 · Protoporfina de estano · Protoporfine stannique · SnPP · Tin protoporphyrin ix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04564833 | Aug 2021 → Nov 2022 | acute kidney injury | Renibus Therapeutics, Inc. | Completed | Met primary |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | stannic protoporfin | “RBT-1 is a combination drug of stannic protoporfin (SnPP) and iron sucrose (FeS) that elicits a preconditioning response through activation of antioxidant, anti-inflammatory,...” PMID 38586479 ↗ Jan 2024 |
| Known as | NSC-267099 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314609 ↗ |
| Known as | Protoporfina de estano | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314609 ↗ |
| Known as | Protoporfine stannique | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314609 ↗ |
| Known as | SnPP | “RBT-1 is a combination drug of stannic protoporfin (SnPP) and iron sucrose (FeS) that elicits a preconditioning response through activation of antioxidant, anti-inflammatory,...” PMID 38586479 ↗ Jan 2024 |
| Known as | Tin protoporphyrin ix | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314609 ↗ |
| Modality | Small molecule | — CHEMBL5314609 ↗ |